Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “γδ T Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Early research (Phase 1)Study completedNCT03790072
What this trial is testing

Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukemia
TC Biopharm 10
Not applicableLooking for participantsNCT07173829
What this trial is testing

Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

Who this might be right for
Glioblastoma
University Hospital, Bordeaux 45
Testing effectiveness (Phase 2)WithdrawnNCT05628545
What this trial is testing

Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

Who this might be right for
Advanced Hepatocellular Carcinoma
Guangdong GD Kongming Biotech LLC
Testing effectiveness (Phase 2)Looking for participantsNCT06106893
What this trial is testing

A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 15
Testing effectiveness (Phase 2)Study completedNCT03183232
What this trial is testing

Safety and Efficiency of γδ T Cell Against Lung Cancer

Who this might be right for
Lung Cancer
Fuda Cancer Hospital, Guangzhou 30
Very early researchNot Yet RecruitingNCT07172178
What this trial is testing

Γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma

Who this might be right for
Malignant Meningioma
Nanjing Medical University 12
Early research (Phase 1)Looking for participantsNCT05302037
What this trial is testing

Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)

Who this might be right for
CancerMalignancyRefractory Cancer+1 more
CytoMed Therapeutics Pte Ltd 12
Early research (Phase 1)UnknownNCT04008381
What this trial is testing

Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 38
Testing effectiveness (Phase 2)Study completedNCT02418481
What this trial is testing

Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

Who this might be right for
Breast Cancer
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Ended earlyNCT01404702
What this trial is testing

Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

Who this might be right for
Neuroblastoma
University of Alabama at Birmingham 4
Testing effectiveness (Phase 2)UnknownNCT04765462
What this trial is testing

Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

Who this might be right for
Malignant Solid Tumours
Chinese PLA General Hospital 60
Early research (Phase 1)Not Yet RecruitingNCT06364787
What this trial is testing

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02425748
What this trial is testing

Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)

Who this might be right for
Lung Cancer
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Ended earlyNCT05369000
What this trial is testing

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Lava Therapeutics 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05664243
What this trial is testing

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
In8bio Inc. 4